Annual EBITDA:
-$156.54M-$43.92M(-38.99%)Summary
- As of today, EWTX annual EBITDA is -$156.54 million, with the most recent change of -$43.92 million (-38.99%) on December 31, 2024.
- During the last 3 years, EWTX annual EBITDA has fallen by -$113.60 million (-264.53%).
- EWTX annual EBITDA is now -1497.20% below its all-time high of -$9.80 million, reached on December 31, 2019.
Performance
EWTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$46.29M-$4.25M(-10.10%)Summary
- As of today, EWTX quarterly EBITDA is -$46.29 million, with the most recent change of -$4.25 million (-10.10%) on September 30, 2025.
- Over the past year, EWTX quarterly EBITDA has dropped by -$6.42 million (-16.10%).
- EWTX quarterly EBITDA is now -1342.89% below its all-time high of -$3.21 million, reached on March 31, 2020.
Performance
EWTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$178.65M-$6.42M(-3.73%)Summary
- As of today, EWTX TTM EBITDA is -$178.65 million, with the most recent change of -$6.42 million (-3.73%) on September 30, 2025.
- Over the past year, EWTX TTM EBITDA has dropped by -$33.65 million (-23.21%).
- EWTX TTM EBITDA is now -5468.80% below its all-time high of -$3.21 million, reached on March 31, 2020.
Performance
EWTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EWTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -39.0% | -16.1% | -23.2% |
| 3Y3 Years | -264.5% | -155.8% | -188.7% |
| 5Y5 Years | -1497.2% | - | - |
EWTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -264.5% | at low | -155.8% | at low | -188.7% | at low |
| 5Y | 5-Year | -1497.2% | at low | -1083.5% | at low | -2409.4% | at low |
| All-Time | All-Time | -1497.2% | at low | -1342.9% | at low | -5468.8% | at low |
EWTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$46.29M(-10.1%) | -$178.65M(-3.7%) |
| Jun 2025 | - | -$42.04M(+7.4%) | -$172.23M(-2.7%) |
| Mar 2025 | - | -$45.41M(-1.1%) | -$167.76M(-7.1%) |
| Dec 2024 | -$156.54M(-39.0%) | -$44.91M(-12.6%) | -$156.58M(-8.0%) |
| Sep 2024 | - | -$39.87M(-6.1%) | -$145.00M(-8.1%) |
| Jun 2024 | - | -$37.57M(-9.8%) | -$134.13M(-10.4%) |
| Mar 2024 | - | -$34.23M(-2.7%) | -$121.46M(-7.8%) |
| Dec 2023 | -$112.63M(-58.4%) | -$33.33M(-14.9%) | -$112.70M(-11.2%) |
| Sep 2023 | - | -$29.00M(-16.5%) | -$101.36M(-12.1%) |
| Jun 2023 | - | -$24.90M(+2.2%) | -$90.45M(-10.5%) |
| Mar 2023 | - | -$25.46M(-15.8%) | -$81.88M(-15.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$71.12M(-65.6%) | -$21.99M(-21.5%) | -$71.12M(-14.9%) |
| Sep 2022 | - | -$18.10M(-10.8%) | -$61.88M(-9.0%) |
| Jun 2022 | - | -$16.34M(-11.1%) | -$56.79M(-11.7%) |
| Mar 2022 | - | -$14.70M(-15.3%) | -$50.86M(-18.4%) |
| Dec 2021 | -$42.94M(-152.5%) | -$12.74M(+2.1%) | -$42.94M(-42.2%) |
| Sep 2021 | - | -$13.01M(-25.0%) | -$30.20M(-75.7%) |
| Jun 2021 | - | -$10.41M(-53.6%) | -$17.19M(-60.8%) |
| Mar 2021 | - | -$6.78M(-73.3%) | -$10.69M(-50.1%) |
| Dec 2020 | -$17.01M(-73.5%) | - | - |
| Jun 2020 | - | -$3.91M(-21.9%) | -$7.12M(-121.9%) |
| Mar 2020 | - | -$3.21M | -$3.21M |
| Dec 2019 | -$9.80M | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Edgewise Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of EWTX is -$156.54M
What is the all-time high annual EBITDA for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual EBITDA is -$9.80M
What is Edgewise Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, EWTX annual EBITDA has changed by -$43.92M (-38.99%)
What is Edgewise Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of EWTX is -$46.29M
What is the all-time high quarterly EBITDA for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly EBITDA is -$3.21M
What is Edgewise Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, EWTX quarterly EBITDA has changed by -$6.42M (-16.10%)
What is Edgewise Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of EWTX is -$178.65M
What is the all-time high TTM EBITDA for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM EBITDA is -$3.21M
What is Edgewise Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, EWTX TTM EBITDA has changed by -$33.65M (-23.21%)